Michael Gelband’s MediWound MDWD Stock Holding History

Michael Gelband’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,460	Closed	-$38K	–	2210
2020 Q3	$38K	Buy	+1,460	New	+$37.3K	﹤0.01%	1646

Other funds holding MDWD

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BOK Financial Tulsa, Oklahoma $7.25B AUM 33.76% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Michael Gelband's MDWD Position: Q4 2020 in Review

Michael Gelband sold out of MediWound (MDWD) in Q4 2020, closing a stake of 1,460 shares — an estimated $38K sold.

Michael Gelband first reported a position in MDWD in Q3 2020 and held it in 1 quarter. The position peaked at $38K in Q3 2020. 28 funds tracked by Wall St. Rank hold MDWD as of Q4 2020.

Michael Gelband reported no remaining MediWound position as of Q4 2020 after selling out during the quarter.
Michael Gelband sold 1,460 MediWound shares in Q4 2020, an estimated $38K.
Michael Gelband first reported a position in MediWound in Q3 2020 and held it in 1 quarter.
Michael Gelband's MediWound position peaked at $38K in Q3 2020.
28 funds tracked by Wall St. Rank held MediWound as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.